These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27668430)

  • 1. Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy.
    Imaizumi T; Nakatochi M; Akiyama S; Yamaguchi M; Kurosawa H; Hirayama Y; Katsuno T; Tsuboi N; Hara M; Maruyama S
    PLoS One; 2016; 11(9):e0163507. PubMed ID: 27668430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary sediment podocalyxin in children with glomerular diseases.
    Kanno K; Kawachi H; Uchida Y; Hara M; Shimizu F; Uchiyama M
    Nephron Clin Pract; 2003; 95(3):c91-9. PubMed ID: 14646369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.
    Ikuma D; Hiromura K; Kajiyama H; Suwa J; Ikeuchi H; Sakairi T; Kaneko Y; Maeshima A; Kurosawa H; Hirayama Y; Yokota K; Araki Y; Sato K; Asanuma YF; Akiyama Y; Hara M; Nojima Y; Mimura T
    Lupus; 2018 Mar; 27(3):484-493. PubMed ID: 29050536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome.
    Zhu B; Li XF; Zhu XL; Lin Y; Zhong S; Zhu CF; Tang XL; Hu YQ; Cheng XX; Wang YJ
    J Nephrol; 2014 Aug; 27(4):411-7. PubMed ID: 24737246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.
    Suwanpen C; Nouanthong P; Jaruvongvanich V; Pongpirul K; Pongpirul WA; Leelahavanichkul A; Kanjanabuch T
    J Nephrol; 2016 Feb; 29(1):37-44. PubMed ID: 25905599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of podocalyxin levels in urinary extracellular vesicles for diagnosis of diabetic nephropathy].
    Wu F; Chen Y; Xiao H; Zou Z; Ning J; Chen H; Zou H
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Aug; 38(9):1126-1130. PubMed ID: 30377108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of urinary podocalyxin as a marker of glomerular injury in obesity-related kidney disease in children and adolescents with obesity compared to urinary albumin creatinine ratio.
    Musa N; Ramzy T; Hamdy A; Arafa N; Hassan M
    Clin Obes; 2021 Aug; 11(4):e12452. PubMed ID: 33797164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C.
    Li JJ; Sa RL; Zhang Y; Yan ZL
    World J Diabetes; 2024 Jun; 15(6):1212-1225. PubMed ID: 38983807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
    Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
    J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and urinary markers of podocyte injury.
    Hara M; Yanagihara T; Itoh M; Matsuno M; Kihara I
    Pediatr Nephrol; 1998 Jan; 12(1):43-8. PubMed ID: 9502567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of determining urinary podocalyxin level in children with primary nephrotic syndrome].
    Liu T; Zhang BL; Li L
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):332-5. PubMed ID: 22613101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocalyxin expression in renal tissues and correlation with the number of urinary podocytes in children with Henoch-Schonlein purpura nephritis.
    Huang D; Wu X; Zheng W; Peng X; He X; Mo S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):161-7. PubMed ID: 22561433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of detecting urinary podocytes in patients with active glomerulonephritis].
    Li JZ; Huang HC; Liu Y; E J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):463-6. PubMed ID: 16224513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
    Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
    Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
    Huang Z; Huang Y; He H; Ni J
    Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of pioglitazone on kidney injury in diabetic rats.
    Peng XH; Liang PY; Ou SJ; Zu XB
    Asian Pac J Trop Med; 2014 Oct; 7(10):819-22. PubMed ID: 25129467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.